Arcutis Biotherapeutics I... (ARQT)
NASDAQ: ARQT
· Real-Time Price · USD
20.88
-0.03 (-0.14%)
At close: Oct 17, 2025, 3:59 PM
20.85
-0.14%
After-hours: Oct 17, 2025, 05:30 PM EDT
Arcutis Biotherapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
Revenue | 196.54M | 59.61M | 3.69M | n/a |
Cost of Revenue | 19.13M | 4.99M | 754K | 763K |
Gross Profit | 177.41M | 54.62M | 2.93M | -763K |
Operating Income | -128.4M | -241.1M | -301.63M | -206.53M |
Interest Income | n/a | n/a | n/a | 173K |
Pretax Income | -139.39M | -259.03M | -311.46M | -206.36M |
Net Income | -140.04M | -262.14M | -311.46M | -206.36M |
Selling & General & Admin | 229.39M | 185.15M | 122.12M | 60.97M |
Research & Development | 76.42M | 110.58M | 182.44M | 145.56M |
Other Expenses | n/a | n/a | n/a | 173K |
Operating Expenses | 305.81M | 295.72M | 304.56M | 206.53M |
Interest Expense | 27.17M | 29.71M | 15.65M | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a |
Cost & Expenses | 324.94M | 300.71M | 305.31M | 206.53M |
Income Tax Expense | 647K | 3.11M | n/a | -454K |
Shares Outstanding (Basic) | 120.96M | 69.31M | 55.03M | 49.41M |
Shares Outstanding (Diluted) | 120.96M | 69.31M | 55.03M | 49.41M |
EPS (Basic) | -1.16 | -3.78 | -5.66 | -4.17 |
EPS (Diluted) | -1.16 | -3.78 | -5.66 | -4.17 |
EBITDA | -109.63M | -227.43M | -294.55M | -205.59M |
EBIT | -112.22M | -229.31M | -295.81M | -206.36M |
Depreciation & Amortization | 2.6M | 1.88M | 1.25M | 763K |
Source: Financial Modeling Prep. Financial Sources.